Clinical Trial Update: Vaccine Treatment in Combination With IL-2 and Treated Lymphocytes for Advanced Melanoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating a vaccine treatment combined with Interleukin-2 and treated lymphocytes for advanced melanoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• Interleukin-2 (interleukin-2)
• Treated Lymphocytes (treated lymphocytes)
• Vaccine Treatment (vaccine treatment)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Melanoma | Phase 2 | Status: COMPLETED